By using human bronchial epithelial cells and PBMC from CF and HSCT patients, respectively, we could show that the <i>IDO1</i> polymorphisms appeared to down-modulate IDO1 expression and function in response to IFNγ or <i>Aspergillus</i> conidia, and to associate with an increased inflammatory response.